Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX4OFI
|
||||
Drug Name |
5-(3-Bromo-phenyl)-6-[(4-cyano-phenyl)-(3-methyl-3H-imidazol-4-yl)-methoxymethyl]-1-methyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile
|
||||
Synonyms |
CHEMBL424448
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H20BrN5O2
|
||||
Canonical SMILES |
CN1C(=C(C=C(C#N)C1=O)c2cccc(Br)c2)COC(c3ccc(cc3)C#N)c4cncn4C
|
||||
InChI |
InChI=1S/C26H20BrN5O2/c1-31-16-30-14-23(31)25(18-8-6-17(12-28)7-9-18)34-15-24-22(19-4-3-5-21(27)10-19)11-20(13-29)26(33)32(24)2/h3-11,14,16,25H,15H2,1-2H3
|
||||
InChIKey |
VXVRUWALANZFFN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.